Earnings Score 65 Neutral

vTv Therapeutics (VTVT) Reports $27M 2025 Net Loss Amid Cadisegliatin Advancements

Mar 18, 2026 00:05 UTC

VTVT, XLV, IHF

Medium term

vTv Therapeutics (VTVT) Reports $27M 2025 Net Loss Amid Cadisegliatin Advancements.

Share this article

Impact

Sentiment

Neutral

Type

Earnings

Horizon

Medium

Risk Level

Medium

AI will analyze the impact on affected symbols and provide trading insights

Get AI-powered insights, advanced filtering, real-time alerts, and unlimited analysis.

Mar 19, 10:17

Stay Ahead of the Markets

Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.